Corrective and Preventive Actions
|
|
|
- Nigel Lynch
- 9 years ago
- Views:
Transcription
1 Corrective and Preventive Actions A Five Step Approach
2 Topics to Be Covered What is CAPA? Governing authority Five steps to a good CAPA process Where companies have difficulty Example citations Recap
3 What Is CAPA? Corrective Action eliminate detected nonconformity Preventive Action prevent nonconformity occurrence
4 CAPA Process Map Deviations/OOS/Failure Problem Occurs Determine Root Cause Determine Corrective Action Initiate CAR
5 CAPA Process Map CAR Respondent(s) and Approver(s) Determined Respondent(s) Provides Corrective Responses, Root Cause Verification, and Implement Due Dates Response(s) Summarized
6 CAPA Process Map Response(s) Approved Corrective Action Implementation begins Respondent(s) review similar systems for Preventive Action Opportunities Effectiveness review date set
7 CAPA Process Map Respondent(s) sign-off when implementation is complete Effectiveness is reviewed and signed-off CAR Closed
8 Governing Authority, FDA CFR Part 211- Finished Pharmaceuticals Subpart J Records and Reports Any unexplained discrepancy shall be thoroughly investigated. The investigation shall extend to other batches that may have been associated with the specific failure or discrepancy. A written record of the investigation shall be made and shall include conclusions and followup.
9 Governing Authority, ICH Q7A Active Pharmaceutical Ingredients Batch Production Records Written procedures should be established for investigating critical deviations or batch failures of intermediate or API to meet specifications. Investigations should extend to other batches.
10 Governing Authority, FDA CFR Part Quality System Regulation Subpart J - Corrective and Preventive Action (a) Manufacturer shall establish procedures for implementing corrective and preventive action. The procedures shall include requirements for:
11 Governing Authority, FDA CFR Part Quality System Regulation Subpart J CAPA cont. (1) Analyzing processes, work operations, concessions, quality audit reports, quality records, service records, complaints, returned product identify existing and potential causes of nonconforming product, or other quality problems statistical methodology shall be employed to detect recurring quality problems
12 Governing Authority, FDA CFR Part Quality System Regulation Subpart J - Corrective and Preventive Action (2) Investigating the cause of nonconformities relating to product, processes, and the quality system;
13 Governing Authority, FDA CFR Part Quality System Regulation (3) Identify action(s) needed to correct and prevent recurrence of nonconforming product and other quality problems; (4) Verifying or validating the corrective and preventive action to ensure actions are effective;
14 Governing Authority, FDA CFR Part Quality System Regulation Subpart J - Corrective and Preventive Action (5) Implement and record changes in methods and procedures needed to correct and prevent identified quality problems;
15 Governing Authority, FDA CFR Part Quality System Regulation Subpart J - Corrective and Preventive Action (7) Submitting relevant information on corrective and preventive actions, for management review.
16 Five Step Approach Identify Implement Verify Review Analyze
17 Where Companies Have Difficulty Identify Implement Verify Review Analyze
18 Why? Incorrect Root Cause Identified! Verify: Problem recurrence Review: PA does not work Implement: CA wrong Identify: Problem but not root cause Analyze: Not done
19 CAPA Subsystems COMPLAINTS MANAGEMENT REVIEW TRAINING CHANGE CONTROL MRB OOS CAPA APR VALIDATION TRENDING AUDITS RECALL DEVIATIONS
20 CAPA Subsystems COMPLAINTS MANAGEMENT REVIEW TRAINING CHANGE CONTROL MRB APR OOS VALIDATION TRENDING AUDITS RECALL DEVIATIONS
21 Example Citations
22 Example Citations - CDER Failure to implement corrective/preventive action or conduct a thorough investigation 21 CFR CFR Examples Repeated test failures not investigated Inadequate investigation of failed particulate inspection
23 Analyze Verify Review Implement Identify
24 Example Citation CDER Q7A Failure to document corrective action regarding instrument calibration check which did not meet specification
25 Analyze Verify Review Implement Identify
26 Example Citation - CBER Failure to establish and maintain adequate procedures for implementing corrective and preventive action, as required by 21 CFR (a) and (b). For-example: (a) The procedure titled corrective Action Handling [redacted] was not approved and implemented to address corrective and preventive action and no established procedure was found to have been in place.
27 Analyze Verify Review Implement Identify
28 Example Citation - CDRH Failure to adequately establish and maintain procedures for implementing corrective and preventive actions as required by 21 CFR (a)(1) Example : a. Corrective Action Request # & # were not closed out by the QC Supervisor as required by (SOP) Corrective and Preventive Action, Rev 1; and
29 Analyze Verify Review Implement Identify
30 Example Citation - CDRH Failure to adequately establish and maintain procedures for implementing corrective and preventive actions as required by 21 CFR (a)(1) Example :(b) (SOP) Corrective and Preventive Action, identifies repair reports as a source for identification of potential CAPA activities; however, repair reports are not being trended or reviewed for CAPA
31 Analyze Verify Review Implement Identify
32 RECAP
33 Recap LACK OF ROOT CAUSE ANALYSIS Identify Implement Verify Review Analyze
34 CAPA Subsystems COMPLAINTS MANAGEMENT REVIEW TRAINING CHANGE CONTROL MRB OOS CAPA APR VALIDATION TRENDING AUDITS RECALL DEVIATIONS
35 Questions?
CAPA Issues and Pitfalls
CAPA Issues and Pitfalls Timothy Barash, BSI April 3, 2014 2 CAPA: Corrective Action, Preventive Action It does NOT mean JUST Corrective Action! A CAPA Story 3 4 Overview A CAPA Story Core CAPA Steps CAPA
Corrective and Preventive Action Background & Examples Presented by:
Corrective and Preventive Action Background & Examples Presented by: Kimberly Lewandowski-Walker Food and Drug Administration Division of Domestic Field Investigations Office of Regulatory Affairs Overview
Combination Products. Presented by: Karen S. Ginsbury For: IFF March 2014. PCI Pharma
Combination Products Presented by: Karen S. Ginsbury For: IFF March 2014 Types of products Biological and medical device (freeze dried + syringe dual volume) Medical device and plasma devised product (syringe)
Library Guide: Pharmaceutical GMPs
Library Guide: Pharmaceutical GMPs Table of Contents Overview...3 Courses Listed by Functional Area... 4 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)... 7 A Tour of the FDA
Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations
Guidance for Industry Quality Systems Approach to Pharmaceutical CGMP Regulations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.
Conducting a Gap Analysis on your Change Control System Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc. Standards, Regulations, Guidelines related to Change Control Management
CAPA - the importance of data analysis
CAPA - the importance of data analysis Presented by: Sue Jacobs QMS Consulting, Inc. 1 847 359 4456 [email protected] QMS Consulting, Inc. 2007 1 Topics Regulatory Requirements Design Controls and
Guidance for Industry. Q10 Pharmaceutical Quality System
Guidance for Industry Q10 Pharmaceutical Quality System U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation
ICH Q10 - Pharmaceutical Quality System
WCC PDA Dinner Meeting Jan 2012 ICH Q10 - Pharmaceutical Quality System Neil Wilkinson NSF-DBA www.nsf-dba.com ICHQ10.1 WCC PDA Dinner Meeting Jan 2012 Your Presenter Partner at NSF-DBA USA Training, Consultancy,
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme
GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme Contents 1. Why good documentation is essential? 2. What constitutes
Inspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 7 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
Mapping Your Success Top Non-Conformities Requiring a CAPA Process
Mapping Your Success Top Non-Conformities Requiring a CAPA Process Agenda FDA Statistics for 2012 BSI Statistics for 2012 EQMS industry benchmark data About CAPA Traits of Software Solution for CAPA 2
Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions
WELCOME Title:: Effective GMP AUDITS for APIs and Formulation Pharma Companies By G.Sundar-Director/Consultant PharmQA Compliance solutions Contents: Introduction GMP Audit GMP Audit plan GMP Auditing
Deviation and Out of Specification Handling
Deviation and Out of Specification Handling APV Training Course GMP Requirements June,10th to11th 2004 Istanbul, Turkey Dr. Jürgen Mählitz GMP Inspector Fronhof 10 D-86152 Augsburg Germany Dr. Jürgen Mählitz
Edwin Lindsay Principal Consultant. Compliance Solutions (Life Sciences) Ltd, Tel: + 44 (0) 7917134922 E-Mail: [email protected].
Edwin Lindsay Principal Consultant, Tel: + 44 (0) 7917134922 E-Mail: [email protected] Corrective and Preventative Action (CAPA) is a system of quality procedures required to eliminate the causes
UNCONTROLLED COPY FOR REFERENCE ONLY
CLOVER MACHINE AND MFG. 800 MATHEW ST. #101 SANTA CLARA, CA 95050 727-3380 727-7015 fax REVISION: DATE: PAGE 1 OF 45 QUALITY POLICY MANUAL DISTRIBUTION LIST: President Purchasing Manager Vice President
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human
Guidance for Industry
Guidance for Industry Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation
Quality Metrics An FDA Perspective PDA Dinner and Dialogue. Melissa Seymour VP, Corporate Quality DRAFT
Quality Metrics An FDA Perspective PDA Dinner and Dialogue Melissa Seymour VP, Corporate Quality DRAFT Agenda How does industry use Metrics? FDA Challenges and Requirements and Use Complexities of Implementation
GxP Process Management Software. White Paper: Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations
GxP Process Management Software : Ten Most Common Reasons for FDA 483 Observations and Warning Letter Citations Most FDA violations involve one of the following: Not having procedures in a regulated area
ORACLE CONSULTING GROUP
ORACLE CONSULTING GROUP 9 Golder Ranch Rd., Ste. 1 Tucson, Arizona 9 Web Site: E-mail: 20-2-0 20-2-0 (FAX) CONSULTING MEMORANDUM QUALITY SYSTEM INSPECTION TECHNIQUE
PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)
January 2013 RESTRICTED PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013) DRAFT FOR COMMENTS Please address any comments on this proposal
Request for Quality Metrics Guidance for Industry
Request for Quality Metrics Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be
Empowering the Quality and Regulatory Compliance Functions
Empowering the Quality and Regulatory Compliance Functions Management must take steps to ensure that regulatory and quality compliance is everyone s responsibility. By: J. Glenn George, Kenneth Imler,
Harmonizing Change Control Processes Globally
Quality & Compliance Associates, LLC Harmonizing Change Control Processes Globally President Quality & Compliance Associates, LLC When We Deal In A Global Environment, How Do We Design A System That Addresses
PHARMACEUTICAL QUALITY SYSTEM Q10
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL QUALITY SYSTEM Q10 Current Step
2014 Annual FDA Medical Device Quality System Data. FDA Form 483 Observations and Warning Letter Citations
2014 Annual FDA Medical Device Quality System Data FDA Form 483 Observations and Warning Letter Citations Why is FDA making these data available? In support of the FDA s Transparency and Case for Quality
Calibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
Case Study: A Mock-QSIT Audit of Ford & Firestone By Tim Wells
Case Study: A Mock-QSIT Audit of Ford & Firestone By Tim Wells Published in ASQ Biomedical Feedback, Volume 30, No. 1, Winter 2001 Background In December the Firestone Company released a report on the
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. [email protected] Overview GMP requirements for Quality Control laboratories
Sandoz Private Limited 10/22/15
Sandoz Private Limited 10/22/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Warning Letter VIA UPS WL: 320-16-01 October 22, 2015
Standard of measurement by which efficiency, performance, progress, or quality of a plan, process, or product can be assessed 1.
Meaningful Metrics What is a Metric? Standard of measurement by which efficiency, performance, progress, or quality of a plan, process, or product can be assessed 1. A quality metric is a measurement of
Effective Root Cause Analysis For Corrective and Preventive Action
Effective Root Cause Analysis For Corrective and Preventive Action Manuel Marco Understanding Key Principles Requirement need or expectation that is stated, generally implied, or obligatory Generally implied
Pharmaceutical Quality Management System: Current Concept
Pharmaceutical Quality Management System: Current Concept Neetu Dubey 1, *, Himanshu Gupta 3, R.K. Sharma 2, Nitin Dubey 1, Nidhi Dubey 4 1. IPS Academy, Indore, Madhya Pradesh, India. 2. Prestige Institute
SUPPLIER QUALITY SYSTEM AUDIT
Company Name: Date: Company Address: Quality Assurance Mgr: President: Number of employees: Is your company receptive to source inspection? List all standards the quality system is based on Web Page: Company
Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1
Annex 2 WHO good manufacturing practices for pharmaceutical products: main principles 1 Introduction 79 General considerations 80 Glossary 81 Quality management in the medicines industry: philosophy and
Audit Report in the framework of the APIC Audit Programme
Audit Report in the framework of the APIC Audit Programme Company Location Address Country Subject of Audit Audit Date Auditor (lead) Co-Auditor(s) Participants Signature of Auditor(s) Lead Auditor Co-Auditor
Best Practice In A Change Management System
Quality & Compliance Associates, LLC Best Practice In A Change Management System President Quality & Compliance Associates, LLC Change Control and Its Role in a Continuous Improvement Environment 3 Benefits
Comparison between FDA QSR and ISO 13485
Comparison between FDA QSR and ISO 13485 Most countries in the world including the Europe, for the conformity assessment of medical devices to be used by their countrymen, assess not only whether the product
FINAL DOCUMENT. Global Harmonization Task Force
FINAL DOCUMENT Global Harmonization Task Force Title: Quality management system Medical Devices Guidance on corrective action and preventive action and related QMS processes Authoring Group: Study Group
Auditing as a Component of a Pharmaceutical Quality System
Auditing as a Component of a Pharmaceutical Quality System Tim Fields Conducting internal audits (or self inspections) and external audits of suppliers and outsourcing operations are key elements of a
ICH guideline Q10 on pharmaceutical quality system
September 2015 EMA/CHMP/ICH/214732/2007 Committee for Human Medicinal Products Step 5 Transmission to CHMP May 2007 Transmission to interested parties May 2007 Deadline for comments November 2007 Final
ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 038-1 26 March 2012 AIDE-MEMOIRE ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION PIC/S March 2012 Reproduction
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy
Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy Global Pharma Sourcing Conference December 6-7, 2011 Philadelphia, USA Nigel J. Smart, Ph.D. Smart Consulting
Guidance for Industry
Guidance for Industry Process Validation: General Principles and Practices U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center
Compliance Case Study #3 Manual Processes, Performance, Responsibilities, and Training
Compliance Case Study #3 Manual Processes, Performance, Responsibilities, and Training Paul L. Pluta, Timothy J. Fields, and Alan J. Smith IMAGEZOO/GETTY IMAGES Compliance Case Studies discusses compliance
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers
Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005 Quality Management System - integrating GMP (ICH
FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS
FAILURE INVESTIGATION AND ROOT CAUSE ANALYSIS Presented By Clay Anselmo, R.A.C. President and C.O.O. Reglera L.L.C. Denver, CO Learning Objectives Understand the Definitions of Failure Investigation and
FINE LOGISTICS. Quality Manual. Document No.: 20008. Revision: A
FINE LOGISTICS Quality Manual Document No.: 20008 Revision: A 20008 Rev. A FINE LOGISTICS, Quality Manual Page 1 of 24 Quality Manual: Table of contents Number Section Page 1. GENERAL 3 1.1 Index and revision
Quality Risk Management ICH Q9 & ISO 14971. Presented by Michael Kerr 11 th November 2011
Quality Risk Management ICH Q9 & ISO 14971 Presented by Michael Kerr 11 th November 2011 Agenda Risk Concept QRM Fundamentals Regulatory Expectations Warning Letters / Observations Application of QRM Introduction:
QW Enterprises, LLP. Quality Manual
QW Enterprises, LLP Quality Manual ISO 9001:2008 Quality Manual 9001 2008 D1 Quality Manual 9001 2008 D1 Page 2 of 34 0 Table of contents 0 Table of contents 2 1 General 5 1.1 Purpose and scope 5 1.2 Application
ISO 9001:2008 Audit Checklist
g GE Power & Water ISO 9001:2008 Audit Checklist Organization Auditor Date Page 1 Std. 4.1 General s a. Are processes identified b. Sequence & interaction of processes determined? c. Criteria for operation
How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters
environmental failure analysis & prevention health technology development How to Use the Design Process to Manage Risk: Elements of Design Controls and Why It Matters Kevin L. Ong, Ph.D., P.E. Managing
SUPPLIER QUALITY SYSTEM AUDIT CHECKLIST
General Information SUPPLIER QUALITY SYSTEM AUDIT CHECKLIST Vendor Code: Phone Fax: Vendor Name: Vendor Address: Completed by: Title: Signature: Date: Management Name: Title: Products/Services Description
Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach
Improved Utilization of Self-Inspection Programs within the GMP Environment A Quality Risk Management Approach Barbara Jeroncic Self-inspection is a well-established and vital part of the pharmaceutical
Process Validation: Practical Aspects of the New FDA Guidance
Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory
Corden Pharma Latina S.p.A. 5/20/16
Corden Pharma Latina S.p.A. 5/20/16 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 Via UPS Warning Letter 320-16-14 Return Receipt Requested
HONG KONG ENVIRONMENTAL ELECTRICAL APPLIANCE COMPANY. Environmental Procedure
HONG KONG ENVIRONMENTAL ELECTRICAL APPLIANCE COMPANY Environmental Procedure Enquiry / Complaint / Nonconformity Handling (EP-07) Revision No. : 1 Prepared by : Mason Lee (EMR) Approved by : Jonathan Ho
QUALITY ASSURANCE MANUAL JPM OF MISSISSIPPI, INC.
QUALITY ASSURANCE MANUAL JPM OF MISSISSIPPI, INC. Hattiesburg, MS Revision E 01/19/11 Revised to ISO 9001:2008 on July 9, 2009 JPM OF MISSISSIPPI, INC. MANAGEMENT QUALITY POLICY It is the goal of JPM of
RTP s NUCLEAR QUALITY ASSURANCE PROGRAM
RTP s NUCLEAR QUALITY ASSURANCE PROGRAM RTP operates under one quality program, whether you purchase products that are commercial grade, nuclear safety-related or industrial safety compliant (IEC 61508).
On-Site GMP Training GMP COMPLIANCE TECHNICAL
PharmaNet On-Site GMP Training GMP COMPLIANCE TECHNICAL 284 E Lake Mead Pkwy Suite C-278 Henderson, NV 89015 Phone: 702-558-0094 Fax: 702-558-0079 www.gmpseminars.com Key to Level of Program Level A: Program
Surgi Manufacturing Quality Manual
Surgi Manufacturing Page 1 of 18 Approvals: QA: Eng. Mgt. : A Date: 18Aug98 1. Introduction... 4 1.1 Scope... 4 1.2 Purpose... 4 1.3 Authority... 4 1.4 Issue of the Manual... 4 1.5 Amendments... 4 1.6
Root Cause Analysis & Systemic Corrective Action
Root Cause Analysis & Systemic Corrective Action Presented by Shannon Craddock of Perry Johnson Registrars, Inc. July 2012 Today s s Agenda Why are we doing this? Audit Finding Actions Taken to Correct
Quality Agreement Template
Quality Agreement Template Prepared by Dan O Leary Ombu Enterprises, LLC 3 Forest Ave. Swanzey, NH 03446 603-209-0600 This document is intended to form the basis for a Supplier Agreement. The document
MEDFORD FABRICATION CSC, INC. Quality System Manual. Date of issue: 03/25/2010 Revision : F
MEDFORD FABRICATION CSC, INC Quality System Manual Date of issue: 03/25/2010 Revision : F Table of Contents System Description 1.0 Introduction 2.0 Company Quality Policy 3.0 Organization Charts 4.0 Quality
Moving from Quality Control to Quality Assurance (Proactive Compliance!)
Moving from Quality Control to Quality Assurance (Proactive Compliance!) Guy Wingate, VP & Compliance Officer Global Manufacturing & Supply, GlaxoSmithKline Disclaimer The views and opinions expressed
Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702
Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.1 Status : APPROVED Effective: 12/11/2014 Page 2 of 23 Quality Manual Table of Contents
Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702
Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 9.2 Status : APPROVED Effective: 9/25/2015 Page 2 of 23 Quality Manual Table of Contents
Preparing for an FDA Pre-Approval Inspection (PAI)
Preparing for an FDA Pre-Approval Inspection (PAI) Jorge Torres CMQ/OE, CQE, CQA July, 2007 1 Agenda Introduction Understanding the PAI Experience: What to Expect Inspection Management Plan Preparing for
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
QUALITY MANAGEMENT SYSTEM (QMS) ASSESSMENT CHECKLIST
1. QUALITY MANAGEMENT SYSTEM QUALITY MANAGEMENT SYSTEM (QMS) ASSESSMENT CHECKLIST 1.1 Quality Management System General 1.1.1 Is objective evidence available to demonstrate that the MDSAP site has defined,
[Project Name] Project Human-Resource Management Plan. [Sub-Project, phase, etc.] [Company] [Company Address]
[Company] [Company Address] Tel: Fax: [Company Phone] [Company Fax] [Company E-mail] May 16, 2015 [Ref. number] Marc Arnecke, PMP [Project Name] [Sub-Project, phase, etc.] The is a component of the Project
Compliance Control Procedure Execution Management System Reduces Compliance Risks by 10X
Compliance Control Procedure Execution Management System Reduces Compliance Risks by 10X By John Helfrich, VelQuest Corporation INTRODUCTION The top drug GMP violations in 2009 involved failings in manufacturers'
ED FAGAN INC. QUALITY SYSTEM MANUAL
ED FAGAN INC. QUALITY SYSTEM MANUAL APPROVED BY: Ed Fagan President ED FAGAN INC. January 13, 2010 TABLE OF CONTENTS 1. PURPOSE AND SCOPE 2 2. PRODUCTS, SERVICES AND CAPABILITIES 2 3. REVISION HISTORY
LIBRARY GUIDE. Online Courses. March 2012
LIBRARY GUIDE Online Courses March 2012 i Table of Contents OVERVIEW..................................................................................... 1 COURSE DESCRIPTIONS (LISTED ALPHABETICALLY)...............................................
Recent Updates on European Requirements and what QPs are expected to do
Recent Updates on European Requirements and what QPs are expected to do QP Forum 28/29 November 2013, Lisbon Dr. Bernd Renger Modified: Georg Goestl 1 Written Conformation for API-Import Actual Status
ORACLE MANUFACTURING EXECUTION SYSTEM FOR PROCESS MANUFACTURING
ORACLE MANUFACTURING EXECUTION SYSTEM FOR PROCESS MANUFACTURING KEY FEATURES ORACLE MES FOR PROCESS INCLUDES: Instruction-driven, operatorfriendly user interface Dispensing Touch Screen based interfaces
When printed the document is for reference only and is considered uncontrolled - refer to the Document Control System for the most current version
QM-1 SUPPLEMENT QUALITY MANAGEMENT SYSTEMS MANUAL Revision 6 Page: 1 of 6 APPROVED BY: TITLE DATE Electronic Signature on file Quality Director 10/3/15 D. Picciotti Page: 2 of 6 DOCUMENT REVISION HISTORY
ICH Q10 Pharmaceutical Quality System (PQS)
ICH Q10 Pharmaceutical Quality System (PQS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Q10 PQS Guideline Background Objectives
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants
Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants Alex D. Kanarek, PhD BioProcess Technology Consultants, Inc. Strategic Institute Quality
Making Recall Determinations
Making Recall Determinations AdvaMed January 23, 2008 Orlando, FL Edward C. Wilson, Jr., Esq. Partner Hogan & Hartson LLP (202) 637-5839 [email protected] www.hhlaw.com Michael S. Heyl, Esq. Associate
Company Quality Manual Document No. QM Rev 0. 0 John Rickey Initial Release. Controlled Copy Stamp. authorized signature
Far West Technology, Inc. ISO 9001 Quality Manual Document No.: QM Revision: 0 Issue Date: 27 August 1997 Approval Signatures President/CEO Executive Vice President Vice President/CFO Change Record Rev
Inspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Jabones Pardo S.A.
CHAPTER 7 - RECALL ACTIVITIES
CHAPTER 7 INVESTIGATIONS OPERATIONS MANUAL 2015 CONTENTS CHAPTER 7 - RECALL ACTIVITIES 7.1.1.1 - Recall SUBCHAPTER 7.1 - RECALLS... 368 7.1.1 - DEFINITIONS... 368 7.1.1.1 - Recall... 368 7.1.1.2 - Recall
Let s skip over the next ten
FOCUS ON... COMPLIANCE Risk-Based Quality Management Systems What Are We Waiting For? by Carol DeSain Let s skip over the next ten years, the changes in FDA policy, politics and leadership; the age-old
Guidance for Industry
Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
Exar Corporation Quality Manual
Exar Corporation Quality Manual Exar Corporation 48720 Kato Road Fremont, CA 94538 Tel: (510) 668-7000 Fax: (510) 668-7001 Executive Quality Improvement Team Commitment This quality manual provides a statement
Annex 2. WHO guidelines on quality risk management. 1. Introduction 62. 2. Glossary 67 3. Quality risk management process 70
Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating
ISO 9001:2000 AUDIT CHECKLIST
ISO 9001:2000 AUDIT CHECKLIST No. Question Proc. Ref. Comments 4 Quality Management System 4.1 General Requirements 1 Has the organization established, documented, implemented and maintained a quality
Aligning Quality Management Processes to Compliance Goals
Aligning Quality Management Processes to Compliance Goals MetricStream.com Smart Consulting Group Joint Webinar February 23 rd 2012 Nigel J. Smart, Ph.D. Smart Consulting Group 20 E. Market Street West
PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7: NON-STERILE PROCESS VALIDATION
April 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES:
Survey Results on The Structure of Medical Device Firms Quality/Regulatory/Compliance Functions
Survey Results on The Structure of Medical Device Firms Quality/Regulatory/Compliance Functions Nancy Singer Compliance-Alliance LLC www.compliance-alliance.com [email protected] Survey Results
ISO 9001:2008 STANDARD OPERATING PROCEDURES MANUAL
8200 Brownleigh Drive Raleigh, NC 27617-7423 Phone: (919) 510-9696 Fax: (919) 510-9668 ISO 9001:2008 STANDARD OPERATING PROCEDURES MANUAL ALLIANCE OF PROFESSIONALS & CONSULTANTS, INC. - 1 - Table of Contents
FDA Inspection Observations The FDA 483 and Beyond. Objectives
FDA Inspection Observations The FDA 483 and Beyond Presenter: David L. Chesney Vice President and Practice Lead PAREXEL Consulting, Waltham, MA [email protected] Objectives Describe history and
Specialties Manufacturing. Talladega Castings & Machine Co., Inc. ISO 9001:2008. Quality Manual
Specialties Manufacturing Talladega Castings & Machine Co., Inc. ISO 9001:2008 This document is the property of TMS and may not be reproduced, wholly, or in part, without the express consent of TMS. Rev.
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
ComplianceSP TM on SharePoint. Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013
TM ComplianceSP TM on SharePoint Complete Document & Process Management for Life Sciences on SharePoint 2010 & 2013 Overview With increasing pressure on costs and margins across Life Sciences, the industry
